248 results about "Acetylcysteine" patented technology

The invention relates to the technical field of biomedicine, and discloses a human metapneumovirus culture method which comprises the following steps: a culture medium is prepared and put into a culture bottle, and the culture medium comprises a DMEM culture medium, glucose, sodium bicarbonate, an HEPES buffer solution, chondroitin sulfate and hyaluronic acid; host cells are selected; preparing a culture solution, wherein the culture solution comprises L-glutamine, bovine serum albumin, antibiotics and N-acetylcysteine; and inoculating the human metapneumovirus into the culture medium for adsorption and infection. The chondroitin sulfate and the hyaluronic acid are added into the culture medium, the chondroitin sulfate and the hyaluronic acid can be combined with glycosaminoglycans on the surfaces of the host cells to form a compound, interaction sites of viruses and the host cells are increased, then virus receptor expression on the surfaces of the host cells is enhanced, the cell membrane environment is optimized, and therefore the anti-tumor effect is achieved. Therefore, the attachment and entry efficiency of the hMPV is improved, and the rapid proliferation of the virus is obviously promoted.

The invention provides a tissue protection solution and application thereof. The tissue protection liquid comprises a basic culture medium; vitamins, wherein the vitamins comprise vitamin E; the antioxidant is prepared from at least one of N-acetylcysteine amide, superoxide dismutase and catalase; and a specific cell factor, wherein the specific cell factor comprises at least one of a ROCK inhibitor Y27632 and insulin. Therefore, when the tissue protection liquid is used for storing and transporting a tissue sample, the loss in the process from tissue sample separation to experiment starting can be reduced, the function and activity of tissue cells are ensured, and the success rate of establishment of various primary tissue cultures is effectively improved.

The invention provides a preparation method and application of mesenchymal stem cell exosomes, and the method is characterized in that N-acetylcysteine and quercetin are added into a culture medium used for culturing MSC cells, so that the MSC cells are stimulated to generate exosomes with anti-aging and anti-apoptosis effects. In addition, the exosome generated by stimulating the MSC through a culture mode of gradually reducing oxygen partial pressure further has an anti-aging effect; the adverse effects of acute oxidative stress, decline of multiplication capacity, unstable quality and the like in a low-oxygen state can be inhibited, and the activity of related components of cells and exosomes is not damaged. The method shows good anti-aging and anti-apoptosis effects in vitro, and a new thought is provided for treating aging diseases by the exosome in the future.

The present disclosure describes methods of administering N-acetylcysteine (NAC) via intranasal nose-to-brain administration. The effect of intranasal NAC nose-to-brain administration can be monitored using an analytical technique, for example, magnetic resonance spectroscopy (MRS). In some embodiments, intranasal nose-to-brain NAC can be used to treat a condition, for example, a brain injury.

Provided herein are compositions and methods for treating patients with Usher syndrome associated retinitis pigmentosa (UARP) comprising identifying that the subject has UARP and administering to the animal or human an effective amount of an N-acetylcysteine amide (NACA) sufficient to protect vision and inhibit degradation of Ellipsoid Zone (EZ) area and retinal sensitivity. In one example, the NACA formulation is doses at 50, 100, 200, 201, 210, 225, 250, 275, 300, 350, 400, 450, 500, 600, 700, 750, 800, 900, or 1,000 mg / day.

The invention relates to the technical field of pharmacy, in particular to a saxagliptin oral preparation and a preparation method thereof. The preparation is prepared from the following components in parts by weight: 5 to 15 parts of saxagliptin or salt thereof, 15 to 30 parts of sodium alginate, 10 to 20 parts of chitosan, 10 to 25 parts of polylactic acid-glycolic acid copolymer (PLGA), 5 to 15 parts of polyvinyl alcohol, 3 to 8 parts of N-acetylcysteine, 2 to 6 parts of vitamin E and 1 to 5 parts of sodium lauryl sulfate. According to the present invention, the drug stability is significantly improved, the chitosan and the sodium alginate are subjected to the polyelectrolyte composite reaction to form the stable gel so as to effectively protect the active components of the drug, and the freeze drying treatment ensures the uniform dispersion and the efficient dissolution of the drug, improves the bioavailability, and enables the drug to be rapidly and fully absorbed and utilized; according to the preparation method, the flexibility of the preparation is improved, the preparation can be easily processed into different dosage forms such as tablets and capsules, the requirements of different patients are met, all the components act synergistically, and the medicine performance is jointly improved.

The invention discloses an electrotransfection solution for pig in-vitro fertilization embryos and application thereof, and belongs to the technical field of pig embryo in-vitro editing. The objective of the invention is to solve the technical problems of low in-vitro electrotransformation efficiency and large damage of pig embryos. The invention provides an electrotransfection liquid for a pig in-vitro fertilized embryo. The electrotransfection liquid is prepared from the following components: a basic liquid which is Opti-MEM, N-acetylcysteine, mannitol and a small-molecule inhibitor Y-27632. According to the technical scheme, the embryo damage in the electrotransfection process can be remarkably reduced while efficient delivery of the gene editing tool is ensured, and a key technical support is provided for establishing a stable and efficient pig embryo gene editing platform.

The invention belongs to the technical field of biochemical multi-item liquid quality control products containing glycocholic acid, and particularly relates to a biochemical multi-item liquid quality control product containing glycocholic acid and a preparation method of the biochemical multi-item liquid quality control product containing glycocholic acid. Comprising a buffer solution, a mixed anti-interference agent of acetylcysteine and cyclodextrin, a stabilizer, a surfactant and a preservative, and the concentration of the mixed anti-interference agent in the quality control product is 0.1%-2% (w / v); the analytes comprise glycocholic acid, total bile acid and other biochemical markers. In order to overcome the defects in the prior art, human serum is taken as a matrix, and a mixed anti-interference agent of acetylcysteine and cyclodextrin is added, so that the problems that glycocholic acid is easy to oxidize and degrade, cross-reacts with total bile acid and the stability of a liquid quality control product is insufficient are solved; the method can realize long-term stable and accurate detection of the liquid quality control product containing CG and multiple biochemical markers.

The present invention discloses an N-acetylcysteine xylitol injection and its preparation method, which comprises raw materials with the following mass-volume ratios: 0.020 - 0.035 g / mL of N-acetylcysteine, 0.015 - 0.030 g / mL of xylitol, 0.005 - 0.010 g / mL of pH regulator, and the balance being injection water. The method of the present invention can reduce the oxidation and degradation of N-acetylcysteine during the preparation of the medicinal solution by controlling the dissolution concentration, temperature and range of the residual headspace oxygen amount of N-acetylcysteine, and selecting a pH regulator with an appropriate concentration to control the pH value of the medicinal solution and controlling the preparation time, thereby improving the stability of the product quality and controlling the generation of related substances. The present invention significantly improves the quality stability of the N-acetylcysteine xylitol injection, ensures the safety of patients' medication, and makes the product have broad application prospects and value.

A powder contains a buffer salt and an amino acid, for example one or both of (i) least one glycine or functional derivative thereof or (ii) at least one N-acetylcysteine, L-cysteine or functional derivative thereof. Optionally the powder additionally includes at least one vitamin or mineral. Preferably the powder has at least one characteristic selected from the group consisting of (i) the amino acid is present in an amount that at least partially comprises the amino acid in a form selected from the group consisting of free form, dipeptides, tripeptides and mixtures thereof and (ii) the powder is substantially free of enzymes and antibodies. The powder can be reconstituted in a liquid containing an acidic component, such as juice or a polyphenol, and / or a protein, such as milk protein, plant protein, collagen or blends thereof. The buffer salt can minimize or prevent denaturation of protein and / or coagulation of protein upon reconstitution of the powder in the liquid.

Provided are a method, an agent, or the like for improving the stability of a medium and for improving the productivity of a recombinant protein. Specifically, provided are: a medium containing N-acetylcysteine and L-cysteine; a method for culturing a cell using a medium containing N-acetylcysteine and L-cysteine; a method for producing a recombinant protein using a medium containing N-acetylcysteine and L-cysteine; and a method, agent, or the like for stabilizing a medium containing L-cysteine using N-acetylcysteine.

The invention relates to the technical field of livestock and poultry breeding, in particular to a goat hybridization breeding method capable of achieving complete-cycle nutrition enhancement. The core of the method is that systematic nutrition intervention runs through the whole breeding process. Before hybridization, performing differential nutrition pretreatment on the parents for 60 days: feeding the female parents with a breeding nutrition enhancer added with components such as D-chiro-inositol and N-acetylcysteine, and supplementing sperm motility enhancer containing acetylated L-carnitine and ergothioneine to the male parents. In the gamete treatment stage, the oocytes are subjected to in-vitro maturation culture in a special culture solution containing components such as D-chiro-inositol and a growth differentiation factor 9; after the sperms are subjected to gradient centrifugal screening, completing in-vitro fertilization in an optimized fertilization culture solution; after the embryos develop into blastocysts in the sequential culture system, carrying out laparoscopic transplantation, and carrying out staged precise nutrition culture on the pregnant ewes. According to the method, through multi-level nutrition enhancement, the reproductive capacity of the goats and the growth performance of offspring are effectively improved.

The invention belongs to the technical field of biology, and relates to a bronchoalveolar lavage fluid (BALF) preserving fluid, a kit and a cytological test method. The preservation solution is composed of TCEP, N-acetylcysteine, EDTA.2Na, trehalose, Proclin300, methanol, sodium chloride and HEPES, and all the components have a synergistic effect to achieve sample viscosity removal, oxidation resistance, corrosion prevention, cell protection and pH stabilization. The preserving fluid is suitable for morphological observation and nucleic acid detection of BALF cells, and can stably preserve samples at room temperature and maintain completeness of cell membranes and clear morphological structure. The kit comprises two preparations which are mixed to form a working solution, and the working solution can be directly used for sample preservation on a sampling site. The cytological test method comprises the steps of sample collection, preservation, centrifugal slide preparation, Wright-Giemsa staining and microscopic observation. Experimental results show that preservation solutions of different formulas are compatible with a chromosome system, the cell morphology is kept stable within 3 days, the dyeing effect is good, and it is proved that the preservation system can remarkably improve the preservation stability and detection reliability of BALF samples and is suitable for cytology and molecular diagnosis application of lower respiratory diseases.

Described herein are compositions and methods for treating lung damage associated with cancer therapy, for example radiation-induced lung damage or chemotherapy-induced lung damage. Lung damage may be treated by administering heparin, optionally formulated with or administered concurrently with N-acetylcysteine. The compositions may be nebulized and administered via inhalation to treat lung damage.

The invention relates to the technical field of biological medicines, in particular to application of N-acetylcysteine in preparation of a medicine for improving intestinal injuries caused by diabetic hyperthyroidism complicated diseases, and the N-acetylcysteine is used for preparing the medicine for improving the intestinal injuries caused by the diabetic hyperthyroidism complicated diseases. The traditional Chinese medicine composition can effectively relieve abnormal blood glucose rise of diabetic hyperthyroidism complications, and improve excessive ingestion and drinking conditions and intestinal injury.

The invention belongs to the technical field of biological enzyme preservation, and particularly relates to a bromelain freeze-drying protective agent and a preparation method thereof. The trehalose and pulullan compound freeze-dried powder injection is prepared from the following components in parts by weight: 30 to 50 parts of trehalose, 8 to 10 parts of pulullan, 3 to 10 parts of maltodextrin, 12 to 22 parts of mannitol, 1 to 4 parts of sorbitol, 4 to 12 parts of glycine, 0.05 to 0.2 part of polysorbate-20, 1.5 to 4.5 parts of a buffering agent, 0.2 to 0.8 part of N-acetylcysteine, 0.05 to 0.3 part of oxidized glutathione, 0.8 to 2.5 parts of PEG (Polyethylene Glycol) and 0.05 to 0.3 part of an antioxidant. According to the invention, trehalose-pullulan is taken as a main skeleton, so that the growth of ice crystals is inhibited, and the water activity is reduced; mannitol constructs a crystal phase support network, and polysorbate-20 stabilizes an interface; sulfydryl is temporarily sealed through oxidized glutathione, and controllable reduction during redissolution is realized through microencapsulated N-acetylcysteine; and a sodium phosphate buffer system keeps the pH stable.

A method for separately quantifying N-acetylcysteine and glutathione in brain tissue includes administering N-acetylcysteine to a subject, acquiring a first magnetic resonance spectroscopy signal from a region of brain tissue of the subject, the first magnetic resonance spectroscopy signal comprising a cysteine β-proton signal, acquiring a second magnetic resonance spectroscopy signal from the region of brain tissue, the second magnetic resonance spectroscopy signal comprising an N-acetyl proton signal, and determining a concentration of N-acetylcysteine in the region of brain tissue based on the N-acetyl proton signal and determining a concentration of glutathione in the region of brain tissue based on a difference between the cysteine β-proton signal and the N-acetyl proton signal.

The invention discloses preparation and application of broad-spectrum antibacterial and antiviral nano-zinc and compound nano-zinc, and belongs to the technical field of medical materials. The method comprises the following steps: mixing a ginkgo leaf extracting solution with a zinc salt aqueous solution, and carrying out reduction reaction under ultrasonic and stirring actions to obtain a nano zinc solution. Adding vitamin C and N-acetylcysteine into the nano-zinc solution, continuously carrying out reduction reaction under the ultrasonic and stirring action, and then uniformly mixing with an isometric aqueous solution containing anti-inflammatory, antipyretic and analgesic components to obtain the compound nano-zinc solution. And uniformly mixing the obtained nano-zinc solution or compound nano-zinc solution with sodium hyaluronate hydrogel with the same mass as the nano-zinc solution or compound nano-zinc solution to obtain nano-zinc gel or compound nano-zinc gel. The method provided by the invention avoids toxic and side effects caused by using chemical reducing agents such as hydrazine hydrate, sodium borohydride and the like to prepare nano-zinc. The nano-zinc and the compound nano-zinc have excellent characteristics of broad spectrum, high efficiency, antibacterial property and antiviral property, and have a good application prospect.

The present application belongs to the technical field of biological enzyme preservation, and particularly relates to a bromelain freeze-drying protective agent and a preparation method thereof. The composition comprises the following components: 30-50 parts of trehalose, 8-10 parts of pullulan, 3-10 parts of malt dextrin, 12-22 parts of mannitol, 1-4 parts of sorbitol, 4-12 parts of glycine, 0.05-0.2 parts of polysorbate-20, 1.5-4.5 parts of a buffer, 0.2-0.8 parts of N-acetylcysteine, 0.05-0.3 parts of oxidized glutathione, 0.8-2.5 parts of PEG and 0.05-0.3 parts of an antioxidant. The present application takes trehalose-pullulan polysaccharide as a main skeleton, inhibits ice crystal growth and reduces water activity; mannitol constructs a crystal phase support network, and polysorbate-20 stabilizes the interface; oxidized glutathione temporarily seals mercapto groups, and microencapsulated N-acetylcysteine realizes controllable reduction during redissolution; and a sodium phosphate buffer system maintains pH stability.

This invention provides the application of a composition in the preparation of drugs for osteoarthritis, belonging to the field of arthritis technology. The composition comprises tofu glycosides, N-acetylcysteine, seaweed peptides, and PDGF. The combination of these drugs significantly enhances the chondrogenic differentiation and migration capacity of chondrocyte stem cells under inflammatory conditions. Furthermore, in an SD rat knee osteoarthritis model, chondrocyte stem cells treated with the enhanced culture medium reduced the Wakitani histological score from 8.83 to 2.17±0.98, demonstrating a superior repair effect compared to traditional methods. Therefore, this invention provides a foundation for the efficient treatment of osteoarthritis.

The invention provides a special culture medium for prostate cancer organoid and a culture method thereof, and belongs to the technical field of biological medicines. The special culture medium for the prostatic cancer organoid is composed of a basic culture medium and a culture additive, and the basic culture medium does not contain exogenously added Noggin recombinant protein and R-spondin recombinant protein. The culture additive is prepared from a basic fibroblast growth factor, a keratinocyte growth factor, a fibroblast growth factor 10, insulin, a p38MAPK signal channel inhibitor, an insulin-like growth factor 1, B27, nicotinamide, N-acetylcysteine, hydrocortisone, a ROCK kinase inhibitor, retinoic acid, interleukin 6, prostaglandin E2, a eriocin and androgen. According to the special culture medium for the prostatic cancer organoid, the culture success rate is increased while the cost is reduced.

The invention relates to the technical field of biological medicine, in particular to a cat triple vaccine immunologic adjuvant containing two cat interleukinins and a metabolism regulating molecule, a composition and application. The composition comprises cat interleukin 15, cat interleukin 23 and metabolic regulation molecules, the metabolic regulation molecules comprise beta-nicotinamide mononucleotide, beta-nicotinamide adenine dinucleotide disodium salt, N-acetylcysteine and L-carnitine, and the composition can be used for preparing a cat triple vaccine or an auxiliary preparation of the cat triple vaccine. The composition can effectively improve the protection capacity of vaccines, prolong the protection time of the vaccines and reduce adverse reactions; the vaccine can reduce or control reproduction infection of viruses in a more durable and higher level mode, the specific humoral immunity level and the memory response capacity of animals are remarkably improved, and invasion and diffusion of FPV, FCV and FHV-1 are better resisted.

It is the object of the present invention a pharmaceutical composition for use in humans or animals containing N-palmitoylethanolamide for the control of the inflammatory and / or neuropathic pain of various origin. In particular, the present invention relates to a pharmaceutical composition comprising palmitoylethanolamide (PEA and L-acetylcarnitine (LAC), optionally with in addition an antioxidant compound such as a polyphenol, alpha-lipoic acid, and L-acetylcysteine.

The invention discloses a CK-MB-containing biochemical multi-term liquid quality control product and a preparation method thereof, and belongs to the technical field of biochemical quality control products, the added substances comprise an adenosine phosphate compound, a creatine compound and an auxiliary stabilizer, the adenosine phosphate compound is at least one of adenosine diphosphate and adenosine triphosphate, and the creatine compound is at least one of creatine triphosphate and creatine triphosphate. The creatine compound is at least one of creatine and phosphocreatine, and the auxiliary stabilizer is at least one of acetylcysteine and beta-mercaptoethanol; and the CK-MB-containing biochemical multi-liquid quality control product is a frozen liquid. The adenylate phosphate compound, the creatine compound and the auxiliary stabilizer are added into the liquid quality control product, so that multiple protection mechanisms can be realized, and the stability of multiple biochemical liquid quality control products containing CK-MB, especially the stability of CK-MB, is obviously improved; errors caused by redissolution are avoided, the detection convenience and accuracy of inspection personnel are greatly improved, and the labor and time cost of a laboratory is reduced.

The application discloses a kind of inhaled acetylcysteine solution clinical use hydrogen sulfide rapid detection device and method, the device includes gas detector, atomizer and atomizing cup, the atomizer is connected by first pipeline seal the detection end of gas detector, the first pipeline is sealed by sealing membrane with atomizing cup is set.The method mainly includes obtaining the concentration of the gas detector in the preset time within the preset time period, the preset time period includes multiple detection times, the time interval between each detection time is equal;With detection time as abscissa, concentration as ordinate, draw curve, calculate the total amount of hydrogen sulfide gas detection curve area.The different time values of hydrogen sulfide can reflect the release characteristics of the drug in clinical use, and the total amount of hydrogen sulfide calculated according to the formula can reflect the situation of hydrogen sulfide in the preparation, which can provide technical guidance for the clinical use of inhaled acetylcysteine solution.

The invention relates to the technical field of biological medicines, in particular to a maintenance solution for culturing influenza viruses as well as a preparation method and application of the maintenance solution. The maintenance liquid comprises a basic culture medium and effective components, the effective components comprise amino acids, vitamins, salts and a virus nutrition enhancer, and the virus nutrition enhancer is a microorganism induced culture extract. The extract is prepared by inoculating fermentation microbial bacteria, performing induced culture through a plant induction factor extract containing American ginseng, polygonum cuspidatum and golden cypress, and then performing autolysis and enzymolysis in the presence of compound metabolic regulatory factors, namely trichosalix A and N-acetylcysteine. The maintenance fluid can significantly enhance host cell metabolism, inhibit cell antiviral response and delay cell apoptosis after infection, so that the culture yield and process stability of influenza viruses are significantly improved under the condition of no dependence on serum.

The present invention provides a special culture medium for breast cancer organoids and a culture method thereof, belonging to the technical field of primary cell culture. A special culture medium for breast cancer organoids is composed of a basal medium and culture additives. The basal medium is DMEM / F12 medium, and the culture additives are composed of epidermal growth factor, basic fibroblast growth factor, keratinocyte growth factor, fibroblast growth factor 10, insulin, transferrin, sodium selenite, A83-01, SB202190, insulin-like growth factor 1, B27, nicotinamide and N-acetylcysteine. The culture medium of the present invention improves the stability of the tumor cell genome during the culture while reducing the culture cost.

The invention relates to the use of scyllo-inositol alone or in combination with other active ingredients including the compound N-acetylcysteine or a derivative thereof to support cognitive health in a subject that takes the product or combination product. The compositions, which are inclusive of oral dosage forms such as tablets or capsules, are provided to the subject which is inclusive of humans or other mammals such as dogs or cats or other animals in need of cognitive improvement. The combination product(s) break up amyloid beta aggregates and promote the clearance of amyloid beta fibrils from the glymphatic system as well as the treatment of disease and conditions that are acerbated by free radicals.

This invention discloses a composite dewatering agent for sludge dewatering in wastewater treatment and its preparation method, belonging to the field of sludge treatment technology. The composite dewatering agent comprises, by weight, the following raw materials: 30-50 parts chitosan-acetylcysteine-modified coal gangue, 20-40 parts cationic starch-modified fly ash fiber, and 1-3 parts nonionic surfactant. The composite dewatering agent of this invention, comprising chitosan-acetylcysteine-modified coal gangue, cationic starch-modified fly ash fiber, and nonionic surfactant, significantly improves the sludge dewatering rate through the synergistic effect of each component, utilizing multiple mechanisms such as charge neutralization, adsorption bridging, and the release of bound water through extracellular polymer destruction. This invention fully utilizes solid waste and natural materials in the preparation of the composite dewatering agent, achieving resource utilization of solid waste while avoiding residual pollution from traditional polyacrylamide flocculants and reducing environmental hazards.